• 25-Hydroxycholesterol-Driven AMPK Activation in Tumor Macrop

  2026-06-23

  Xiao et al. (2024) identify a lysosomal 25-hydroxycholesterol–AMPK–STAT6 axis that metabolically reprograms tumor-associated macrophages (TAMs) toward an immunosuppressive state. This mechanistic insight highlights CH25H and AMPK as actionable nodes for modulating the tumor microenvironment and enhancing immunotherapy responses.

• METTL3-m6A-LEPR Axis Regulates Fetal Growth Restriction Path

  2026-06-22

  This study uncovers how METTL3-mediated N6-methyladenosine (m6A) modification of the leptin receptor (LEPR) critically regulates trophoblast function and fetal growth restriction (FGR). By integrating molecular, cellular, and animal models, it identifies the METTL3-m6A-LEPR pathway as a mechanistic link in FGR and proposes new biomarkers for predicting adverse pregnancy outcomes.

• Ibrutinib-Induced AF: CSK Inhibition as the Mechanistic Driv

  2026-06-22

  The referenced Circulation study uncovers that the increased risk of atrial fibrillation (AF) observed with ibrutinib therapy is due to off-target inhibition of C-terminal Src kinase (CSK), not its intended Bruton tyrosine kinase (BTK) target. This finding clarifies the molecular basis of ibrutinib’s cardiac side effects and highlights the need for kinase inhibitor selectivity to minimize arrhythmogenic risk.

• Linoleic Acid (C18:2(9Z,12Z)): Technical Guide for Lab Assay

  2026-06-21

  Linoleic Acid (C18:2(9Z,12Z), SKU C3108) is an essential fatty acid used to model oxidative stress, membrane fluidity, and nutritional deficiency in cellular and animal research. This reagent is unsuitable for protocols requiring aqueous solubility or long-term stock storage, but it is highly effective in workflows focused on lipid signaling, oxidative mechanisms, and barrier function. The following technical article provides actionable guidance for researchers seeking robust results with Linoleic Acid.

• E. coli Uracil-DNA Glycosylase (UDG): Technical Workflow Gui

  2026-06-20

  E. coli Uracil-DNA Glycosylase (UDG) is designed to excise uracil from DNA, helping researchers prevent PCR product contamination and maintain amplification fidelity. This enzyme is not suitable for RNA substrates, short oligonucleotides (<6 bases), or any diagnostic or medical use.

• Targeted Gene Silencing in GDM: ATS-9R/siCcl2 for Insulin Re

  2026-06-19

  The referenced study pioneers a targeted gene delivery approach for gestational diabetes mellitus (GDM) by leveraging the ATS-9R/siCcl2 complex to silence Ccl2 in adipose tissue macrophages. This strategy demonstrates significant reductions in adipose inflammation and insulin resistance, offering a precise tool for metabolic disease research.

• SFRP1 Modulation of Wnt/β-Catenin Pathway in Oral Fibrosis

  2026-06-19

  The referenced study identifies SFRP1 as a key modulator that alleviates oral submucous fibrosis (OSF) by reducing neutrophil infiltration and inhibiting the Wnt/β-catenin pathway. These mechanistic insights advance our understanding of OSF pathogenesis and highlight new avenues for targeting fibrotic signaling in oral disease.

• Tetrahydromagnolol: Precision CB2 Agonist for GPCR Signaling

  2026-06-18

  Tetrahydromagnolol empowers researchers to dissect peripheral CB2 receptor signaling with unprecedented selectivity and potency, making it a standout tool for advanced cannabinoid and anti-inflammatory research. Its dual action as a CB2 agonist and GPR55 antagonist unlocks novel experimental strategies in cancer metastasis and inflammation models.

• Epinephrine Bitartrate: Strategic Guidance for Translational

  2026-06-18

  This thought-leadership article explores how (-)-Epinephrine (+)-bitartrate, a gold-standard adrenergic receptor agonist, bridges mechanistic insight and translational utility. We analyze its unique pharmacology, protocol optimization for cardiovascular and neurobiology research, and its strategic role in addressing unmet clinical needs, including arrhythmia management. The discussion integrates competitive landscape analysis, protocol recommendations, and an outlook on advancing sympathetic nervous system research, all while highlighting APExBIO’s commitment to quality and reproducibility.

• Streptavidin – Cy5: Precision Biotin Detection for Oncology

  2026-06-17

  Streptavidin – Cy5 empowers researchers with ultrasensitive, reproducible biotin detection across immunofluorescence, IHC, and flow cytometry platforms. Its Cy5 conjugation streamlines multiplexed analyses, making it a cornerstone for robust apoptosis pathway studies in cancer biology. Discover actionable protocol and troubleshooting insights grounded in recent breast cancer research.

• Tropisetron Hydrochloride: 5-HT3 Receptor Antagonist in Benc

  2026-06-17

  Tropisetron Hydrochloride stands out as a highly selective 5-HT3 receptor antagonist and α7-nicotinic receptor agonist, enabling precise modulation in serotonin receptor signaling research. This guide details experimental workflows, troubleshooting, and innovative applications, with insights from recent transporter inhibition studies.

• Ciprofloxacin in Laboratory Research: Reliability and Best P

  2026-06-16

  This article explores how APExBIO's Ciprofloxacin (SKU A8399) addresses key challenges in cell-based and antimicrobial assays. Through scenario-driven analysis, it demonstrates the compound’s high analytical purity, consistent mechanism of action, and workflow compatibility—delivering data-backed solutions for experimental reproducibility and reliability.

• Dibutyryl-cAMP, Sodium Salt: Optimizing cAMP Pathway Workflo

  2026-06-16

  Dibutyryl-cAMP, sodium salt (DBcAMP sodium salt) empowers precise activation of cAMP-dependent signaling, enabling advanced cell fate, inflammation, and neurobiology studies. This article delivers stepwise protocols, troubleshooting strategies, and actionable insights based on the latest mechanistic research—bridging high-impact discovery with reliable APExBIO reagents.

• IEM 1460: Unraveling AMPA Blockade for Neurotoxicology Resea

  2026-06-15

  Discover how IEM 1460, a selective AMPA receptor blocker, advances excitotoxicity and neuroprotection research. This article delivers a deep mechanistic dive and highlights best practices for leveraging IEM 1460 in cutting-edge neuroscience experiments.

• Ciprofloxacin in Translational Research: Mechanisms and Stra

  2026-06-15

  This thought-leadership article explores the central role of Ciprofloxacin—a high-purity fluoroquinolone antibiotic from APExBIO—as both a mechanistic probe and a strategic asset in translational antimicrobial resistance research. Integrating recent findings on carbapenem-resistant Enterobacter cloacae (CREC), it provides actionable guidance for experimental design, protocol optimization, and future research priorities.

456 records 14/31 page Previous Next First page 上5页 1112131415 下5页 Last page